Hillary Stires

Hillary Stires supports clients in navigating the regulatory strategy and FDA policy environment.

Trained as a comprehensive cancer biologist and endocrinologist, Hillary provides technical knowledge of cancer treatment from a multifaceted approach including translating technical information.

Prior to joining Avalere, Hillary was a postdoctoral fellow at Georgetown University’s Lombardi Comprehensive Cancer Center where she studied endocrine resistance in breast cancer. Currently, Hillary helps clients develop market access strategies including scientific and regulatory requirements for FDA approval and success in public and private reimbursement.

Hillary has a BS in behavioral neuroscience from Lehigh University and a PhD in endocrinology and animal biosciences from Rutgers University.

Authored Content

Announced this past August, the US Preventive Services Task Force (USPSTF) expanded risk assessment and genetic testing recommendations for BRCA-related cancers and recommendations for risk-reducing therapies. This expansion marks the growing importance of genetic literacy in the healthcare system.